Close

Apollo Endosurgery (APEN) Endosurgery Announces First ORBERA U.S. Post-Approval Publication

February 26, 2018 5:28 PM EST Send to a Friend
Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq: APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login